Virtual drug company
Cost effective innovation power »Synergistics technologies
Bodyguarding diseases at endothelial barriers »Drug candidates
Large indications with unmet medical needs »Recent news
Euroopan unionilta 6 miljoonaa euroa Faronin Traumakineohjelmalle
20121129_fi.pdf (830.1 kt)Faron was granted the final Young Innovative Company support by Tekes
20121101.pdf (940.8 kt)New data from the FPCLI001 study presented at the 2012 ATS meeting
20120521.pdf (56.2 kt)Faron is a virtual drug company focusing to discovery and development of proprietary new compounds/use for:
- vasculopathies
- traumas
- inflammation
- metastasis